A jury has granted a Georgia couple $4.3 million in damages through a premature birth injury lawsuit filed over the death of their infant son. In total, they received $3.5 million for the loss of their baby, $200,000 for the child’s pain and suffering, $600,000... Read More

The parents of a 21-year-old Vermont woman who died after receiving treatments for cerebral palsy are suing Allergan, the manufacturers of the Botox that was used during her therapy. Mike and Susan Fortuna, of Shellbourne, VT, filed the lawsuit on April 9th over the death... Read More

In April, 2015, federal judge Joseph R. Goodwin of the United States District Court for the Southern District of West Virginia faced a legally complex analysis regarding the applicability of punitive damages in an ongoing transvaginal mesh product liability case against Boston Scientific Corporation. Procedurally,... Read More

A jury in Los Angeles has awarded a 73-year-old woman a $13 million verdict in a lawsuit in which lawyers for the plaintiff claimed that she contracted a deadly form of cancer by using asbestos-containing talcum powder. The jury arrived at the verdict on April... Read More

Last month, an Irish mother testified before a Medical Council after her infant son suffered hypoxia during the birth process. Her Tipperary doctor faces allegations of poor professional performance in relation to the now two-year-old boy. The mother filed a birth injury lawsuit against the... Read More

According to a recently published research study, popular anticoagulant drugs Xarelto and Pradaxa may pose a heightened risk of serious gastrointestinal bleeding in patients who choose them instead of more traditional blood thinning medications such as warfarin. The study, undertaken by researchers from Johns Hopkins... Read More

Medical device manufacturer Boston Scientific Corp., facing more than 25,000 transvaginal mesh lawsuits in federal and state courts because of its allegedly flawed "Pinnacle" product announced last week that it has reached its first settlement agreement amounting to $119 million to resolve 2,970 cases. Boston... Read More

Takeda Pharmaceuticals has agreed to a $2.4 billion Actos settlement that would largely resolve thousands of claims regarding the drug’s risk of bladder cancer. The company said that the settlement would go into effect if at least 95% of current plaintiffs accept it; in this... Read More